The present study further showed that Cbl-b inhibited breast cancer cell migration by suppressing the activation of c-Src, ERK and Akt, indicating that Cbl-b inhibited RANKL-induced breast cancer cell migration via the Src-ERK/Akt pathway. The gene discussed is AKT1; the disease is breast carcinoma.